Global Population Health Management Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387641
  • Report
  • Region: Global
  • 206 pages
  • Mordor Intelligence
1 of 4
The Global market for Population Health Management is poised to reach $XX million by the end of 2020. Population Health Management (PHM) aims to better the health outcomes of a group by monitoring and identifying individual patients within that group. They use Business Intelligence tools to aggregate, analyze data and provide meaningful insights which will aid in the process of decision making from a patient perspective. Using this data, effort is made to improve the clinical outcomes while lowering costs. Care management is a dire constituent of PHM, and while the goals of care management can vary from organization to organization, they tend to revolve around refining patient self-management, improving medication management, and reducing the cost of care such as admit rates.Currently, North America is the largest market for Population Health Management. This can be attributed to the increase in the number of Government initiatives towards adopting the PHM system. Asia Pacific is the fastest growing segment for the future.

The Global Patient Health Management market can be classified on the basis of Component (Hardware, Software, Services), Application (Clinical case reports, compliance programs, health economics, ROI, resource management, care coordination & provider incentives), Delivery mode (On-premise, cloud based, web based & mobile based), End user (Payers, Providers, Employer groups, & Government organizations) and Geography (North America, Europe, APAC & RoW).DriversIntroduction of Patient protection & Affordable Care Act (ACA) encouraging hospitals to take up PHM programs, emergence of big data analytics, rise in demand for better patient quality of life, rise in demand to reduce healthcare costs and increasing incidences of chronic disease population are the major factors boosting the market growth.RestraintsData management & safety of the data concerns, lack of trained professionals and the lack of a presence of a proper system which requires investment to run PHM smoothly are the major challenges faced by the PHM market.

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the Global Population Health Management Market, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

Identification and analysis of the Macro and Micro factors that affect the Global Population Health Management market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report Description
1.2 Research Methodology
2. Key Findings
3. Executive Summary
4. Market Dynamics
4.1 Market Segmentation
4.2 Market Drivers
4.2.1 Growth of personalized medicine boosting the market growth
4.2.2 Upsurge of Cancer patients booming the market growth
4.2.3 Increasing opportunities in Digital Pathology
4.2.4 High demand for companion & molecular diagnostics
4.3 Market Restraints
4.3.1 Limited customer base for tissue diagnostics
4.3.2 Limted budget hindering the growth of the market
4.3.3 Regulatory framework issues
5. Global Market Segmentation
5.1 By Technology
5.1.1 H&E Slide Staining
5.1.2 Immunohistochemistry (IHC) IHC Detection Systems IHC Primary Antibodies Research IHC Detection Others
5.1.3 In-Situ Hydbridization (ISH) ISH Detection Systems Research ISH Detection ISH Probes Others
5.1.4 Special Stains
5.1.5 Digital Pathology Dermatopathology Lung Pathology Colorectal Pathology Breast Pathology Hematopathology Prostate Pathology Cervical Cancer Diagnostics
5.2 By Platform
5.2.1 High Throughput Scanning (HTS)
5.2.2 Brightfield Scanning
5.2.3 H&E Staining
5.2.4 Image Management
5.2.5 IHC/ISH Staining
5.2.6 Specimen Workflow
5.2.7 Speical Stains
5.2.8 Research IHC/ISH
5.3 By Application
5.3.1 Prostrate Cancer
5.3.2 Lung Cancer
5.3.3 Colorectal Cancer
5.3.4 Breast Cancer
5.3.5 Skin Cacner
5.3.6 Cervical Cancer
5.3.7 Lymphoma
5.3.8 Gastric Cancer
5.3.9 Others
5.4 By Product
5.4.1 Instruments
5.4.2 Reagents
5.4.3 Others
5.5 By End User
5.5.1 Research Labs
5.5.2 CRO
5.5.3 Hospitals
5.5.4 Pharmaceuticals
5.5.5 Others
5.6 By Geography
5.6.1 North America US Canada Mexico
5.6.2 Europe UK Germany France Spain Italy Rest of Europe
5.6.3 Asia Pacific China Japan India South Korea Rest of Asia Pacific
5.6.4 Rest of the World
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Abbott Laboratories
7.2 Roche
7.3 Sigma Aldrich
7.4 Life Technologies
7.5 Danaher Corporation
7.6 Agilent Technologies
7.7 Biogenex Laboratories
7.8 Cell Signalling Technology
7.10 Affymetrix
7.11 Cancer Genetics,Inc.
7.12 Definiens
7.13 Genomic Health, Inc.
8. Appendix
8.1 Abbreviations
8.2 Sources
8.3 Bibliography
8.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown